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Abstract
Chronic pain can be understood not only as an altered functional state, but also as a consequence of neuronal plasticity.
Here we use in vivo structural MRI to compare global, local, and architectural changes in gray matter properties in patients
suffering from chronic back pain (CBP), complex regional pain syndrome (CRPS) and knee osteoarthritis (OA), relative to
healthy controls. We find that different chronic pain types exhibit unique anatomical ‘brain signatures’. Only the CBP group
showed altered whole-brain gray matter volume, while regional gray matter density was distinct for each group. Voxel-wise
comparison of gray matter density showed that the impact on the extent of chronicity of pain was localized to a common
set of regions across all conditions. When gray matter density was examined for large regions approximating Brodmann
areas, it exhibited unique large-scale distributed networks for each group. We derived a barcode, summarized by a single
index of within-subject co-variation of gray matter density, which enabled classification of individual brains to their
conditions with high accuracy. This index also enabled calculating time constants and asymptotic amplitudes for an
exponential increase in brain re-organization with pain chronicity, and showed that brain reorganization with pain
chronicity was 6 times slower and twice as large in CBP in comparison to CRPS. The results show an exuberance of brain
anatomical reorganization peculiar to each condition and as such reflecting the unique maladaptive physiology of different
types of chronic pain.
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Introduction
Increasing evidence supports the idea that chronic pain could be
understood not only as an altered perceptual state, but also as a
consequence of peripheral and central neuronal reorganization.
Studies in animal models of chronic pain have demonstrated that
sustained pain is accompanied with molecular, neuronal, and
structural changes in the periphery and the spinal cord [1]. Recent
anatomical and functional imaging studies in humans are
beginning to provide insights into the brain reorganization
associated with chronic pain. Different chronic pain conditions
seem to evoke distinct brain activity patterns, which reflect not
only pain but also the clinical manifestations associated with the
disease [2,3]. In addition there is accumulating evidence that
chronic pain alters brain dynamics beyond pain perception by
distorting spatial and temporal properties of the brain default
mode network (DMN), first shown in chronic back pain (CBP)
patients for an attentional task [4], and now also seen during
resting state in multiple chronic pain conditions [5,6,7]. Moreover,
chronic pain is associated with distorted information flow in brain
reward/motivation circuitry [8].
Brain reorganization for chronic pain has also been investi-
gated by comparing its morphology between chronic pain and
healthy controls. Altered brain morphology was first shown for
CBP patients [9,10] and is now reported in many pain conditions,
including fibromyalgia [11,12,13,14], complex regional pain
syndrome (CRPS) [15], osteoarthritis (OA) [16,17], irritable bowl
syndrome [18,19,20], headaches [11,21,22,23], chronic vulvar
pain [24], in females suffering from menstrual pains [25], as well
as in animal models of chronic pain [26,27]. Across the human
studies the most consistent observation is regional decreases in
grey matter in the pain patients (although increases and no
change are also reported) and, even though many studies
emphasize involvement of brain regions associated with pain
processes, the data also suggests that unique brain regions are
impacted in different types of chronic pain. Most importantly, it
remains unclear whether morphological reorganization exclu-
sively impacts pain processing circuitry and whether the sites of
local reorganization mirror specific patterns of brain functional
states seen for distinct types of chronic pain (for differing views
see [2,17,28,29]).
Recent studies demonstrate that many of the gray matter
changes observed in pain patients subside with cessation of pain
[16,17,30]. In addition, it has been shown that the observed
morphological differences in chronic pain conditions often
correlate to the number of years of pain individuals have been
suffering with the condition as well as its intensity [9,12,15,28].
These results suggest that the brain morphological changes may
be reversible in nature and are a consequence of pain perception.
However, this pain perception is embedded in a larger
maladaptive context, wherein physical movement, daily function,
and mood are reshaped by the presence of pain. Within this
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also reflect experience/learning dependent changes underlying
the specific pathology and consequent cognitive/behavioral cost
of the disease [31,32]. However, our understanding of the extent
and nature of morphological distortions and the specificity of
these changes in different chronic pain conditions may be
critically limited using the standard assessment methods. The
majority of human brain morphometric studies are based on
voxel-wise comparisons between groups. Implicit in such analyses
is the assumption that expected changes are local and do not
interact with each other. However, if brain morphometry is being
re-carved as a consequence of coping, suffering, and related
behavioral changes, then the interaction across brain regions
should also be distorted with chronic pain, which can be studied
when brain grey matter is viewed as an interconnected network.
Here we evaluate changes in brain structure using high-field
magnetic resonance imaging (MRI) in three chronic pain patient
groups: CBP, CRPS, OA, relative to healthy matched controls.
The primary hypothesis tested is that distinct brain morpholog-
ical changes are associated with different chronic pain types. We
examine the latter at the voxel level, and more grossly when the
brain is parceled into Brodmann areas-based subdivisions. We
also test for the impact of extent of chronicity of pain on brain
morphology by examining its influence commonly across chronic
pain types. Given that different chronic pain conditions seem to
underlie distinct brain functional networks and recent studies link
changes in brain functional connectivity to anatomical connec-
tivity [33,34], we advance and test the hypothesis that the brain
grey matter when viewed as a network will exhibit distinct
properties for different chronic pain conditions. Moreover, we
develop a novel approach for quantifying morphological changes
based on an index derived from within subject co-variation of
brain gray matter, and demonstrate that this approach accurately
classifies individuals to their respective clinical chronic pain
conditions. The latter index provides a measure with which we
could also quantify the time course and amplitude for re-
organization of the brain grey matter network with pain
chronicity.
Results
Total neocortical gray matter volume is lower only in CBP
Differentiating normal age-related changes from the effect of
disease on the total brain volume may potentially provide new
insights regarding mechanisms of chronic pain. Here we compare
total neocortical grey matter (GM) volume between the three
patientgroupsand controls,aftercorrectingforintracranialvolume,
gender, and age. Total neocortical GM volume showed a significant
difference across groups (F (4,128) =4.19; p =0.022) (Figure 1A).
Post-hoc comparisons showed that only the CBP patients exhibited
a significant decrease in neocortical GM volume when compared to
healthy controls (p=0.008). Total ventricular volume (sum of 3
rd
and 4
th ventricle volumes) was also measured as a control and did
not differ across groups (F (4,128) = 1.08; p =0.48).
Males and females did not differ in neocortical GM volume
(across all subjects) (F(1,128) =1.54; p =0.22) (Figure 1B). When
we examined the relationship of total neocortical GM volume to
age we observed a strong negative correlation for all groups
(healthy age dependent slope: 22.01, R=0.77, p,0.01; CBP age
dependent slope: 22.43, R=0.65, p,0.01; CRPS age dependent
slope: 22.15, R=0.64, p,0.01; OA age dependent slope: 23.00,
R=0.51, p=0.02) (Figure 1B). These age-related decreases
were similar for all groups and matched previous estimates
[9,15,35,36].
Voxel-wise and gross regional analyses reveal specific
patterns of decreased gray matter density for each
chronic pain condition
VBM is a flexible voxel-wise whole-brain statistical analysis
technique that can be used to assess between-group differences in
local brain tissue content and to examine correlations between tissue
content and other measures of interest. To identify regional increases
or decreases in GM density for the different pain conditions, each
group was entered as a condition into a separate model, and linear
contrasts performed againstage and gender matched healthy controls
(unpaired t-test, t-score .3.0, corrected for multiple comparisons
across space using permutation testing, clustering determined using
TFCE). Only significant decreases of GM density were observed in
the patients relative to healthy controls. The three VBM statistical
maps show distinct regional GM density decreases for each chronic
pain group (Figure 1C, Figure S1). CBP was associated with
decreased GM density in bilateral posterior insula, secondary
somatosensory cortices, pre- and post-central regions in addition to
hippocampus and temporal lobes. CRPS showed decreased GM
density primarily in the anterior insula and orbitofrontal cortex.
Decreased GM density in OA was localized to portions of the insula
and mid ACC in addition to the hippocampus, paracentral lobule
and regions of the inferior temporal cortex (Table S1).
It is interesting to note that GM decrease in densityinchronic pain
patients showed distinct amounts of overlap between conditions. The
OA VBM map showed 89.7% overlap with that of CBP. The CRPS
was the most dissimilar of the 3 patient groups and it showed 8.7%
o v e r l a pw i t hC B Pa n d9 . l %w i t hO A .I na d d i t i o n ,G Md e n s i t y
decreases were not limited to regions that have been shown to be
involved in pain perception, representation, or modulation. For
example, all groups exhibited decreased GM density in the inferior
temporal gyrus, and CBP and OA also showed decreased GM
density in the hippocampus and visual cortex, brain regions that do
not receive direct input from the ascending nociceptive pathways and
are not implicated in processing painful information.
In addition to voxel-wise VBM, we examined GM density changes
at a more gross level by parceling the brain to 82 predefined ROIs
and computing mean GM density in each ROI, as derived from the
VBM analysis. The 82 regions comprised 41 cortical regions in each
hemisphere, corresponding approximately to classical Brodmann
areas. Similar to the voxel-wise VBM analysis, age, gender, and total
intracranial volume were regressed out. Differences in GM density
across the four subject groups for all ROI-s were tested using a 1-way-
ANOVA (corrected for multiple comparisons using the Holm-
Bonferroni correction). Results for the comparison are shown in
Figure 1D, and generally agree with the results obtained with voxel-
wise VBM comparisons. Regions that best differentiated GM density
between the groups included pain related areas such as secondary
somatosensory cortex, bilateral insula, and dorsal and orbital fontal
regions, in addition to regions not specifically related to pain
processing: the hippocampus and occipital cortex.
Relating grey matter density decreases to chronicity of
pain
To elaborate on the specificity of GM density changes in relation
to clinical pain parameters, we first performed a whole-brain voxel-
wise correlational analysis between GM density results obtained by
VBM and pain intensity, pain duration, and their interaction
independently for each group. Previous reports indicated that the
degree of GM density changes show a relationship with duration
and intensityof pain in different pain conditions [9,12,15,22]. In the
present study GM density did not show any significant correlations
with pain duration, intensity or their interaction for any group.
Anatomical Changes in Chronic Pain
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drug usage to GM density changes. We performed a whole-brain
voxel-wise correlation analysis between GM density results
obtained by VBM and Beck Depression Inventory (BDI), Beck
Anxiety Inventory (BAI), and Medication Quantification Scale
(MQS) scores independently for each group. GM density did not
show any significant correlation with anxiety, depression or MQS.
In addition the relationship between GM density and pain
intensity and/or duration did not change when anxiety, depression
and medication use were used as covariates of no interest.
In contrast, when we examined the effect of chronicity of pain
irrespective of pain duration type (voxel-wise VBM contrast
between short duration.long duration for all patients; separated
by the median of pain duration=5.1 years, Figure 2A, 2B), we
observe multiple brain areas distinguishing between short and long
duration chronic pain (Figure 2C), where we again observe only
Figure 1. Cortical gray matter changes in three chronic pain conditions assessed at multiple scales. A. Average total neocortical gray
matter (GM) volume for the three patient groups, CBP (n=36), CRPS (n=28) and OA (n=30), and healthy controls (n =46). Group effect was assessed
using an ANCOVA with age, gender and intracranial volume as confounds and was significant (F (4,128) =4.19, P =0.022). Planned pair-wise contrasts
between each chronic pain group and healthy controls showed that only CBP exhibited a significant decrease in total neocortical GM volume
(p,0.01). B. Bargraph shows that total neocortical GM volume did not differ by gender across the groups (F (4,128) =1.54, P =0. 22). Scatter plot
presents neocortical GM volume in relation to age for each subject, color-coded by group. All patient groups and healthy controls exhibit a significant
negative correlation between neocortical GM volume and age. Right panel shows the slopes computed independently for each group, which did not
differ from each other. C. Gray matter morphological changes assessed by voxel based morphometry (VBM). The three groups of patients were
contrasted separately to specifically matched healthy controls. Shown are the t-test statistics maps for patients,controls (t-score .3.0, corrected for
multiple comparisons across space by permutation testing, clustering determined using TFCE). The three patient groups exhibited distinct cortical
patterns of regional gray matter density decreases (CBP =red, CRPS=yellow, OA=blue). D. Gray matter morphological changes assessed by ROI
based GM density comparison. The cortex was subdivided into 82 predefined regions, which approximate the left and right hemisphere Broddmann
areas. Gray matter density was averaged across all voxels within each ROI and compared across groups after correcting for age, gender and global
brain volume. Plot shows the F-value for across group comparison, green line indicates significance threshold (F (1,124).2.7). Brain regions above
threshold are labeled and include multiple frontal regions, insula, secondary somatosensory cortex (SII), hippocampus, and occipital cortex.
doi:10.1371/journal.pone.0026010.g001
Anatomical Changes in Chronic Pain
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The brain areas identified were mainly sensory and motor regions
as well as bilateral insula. As a case example, and a post-hoc
regional analysis, we extracted the peak GM density for the right
insula and compared its values between healthy subjects, and short
and long duration groupings for chronic pain patients. GM density
for the insula (healthy: 0.5360.06, short duration: 0.5460.05,
long duration: 0.4760.06; values expressed as mean6S.D) was
significantly lower in the long duration group compared to the
healthy (unpaired t-test, t=22.56, p ,0.05) and short duration
groups (t,22.78, p,0.05) (Figure 2D). Moreover, the right
insula GM mean showed a tight correlation with individual
subjects’ pain duration (log scale), only for the group with long
duration chronic pain (R=0.79, p,0.01; Figure 2E). These
Figure 2. Relationship between Gray matter density and duration of chronic pain. A) Distribution of pain duration for all patients. Patients
were divided into 2 subgroups (short duration and long duration) based on the median (median duration=5.1 years, dashed line). B) Pie charts show
the frequency of each patient population for the 2 subgroups. C) Brain regions that exhibit significant decreased GM density for long duration
compared to short duration pain (voxel-wise VBM, unpaired t-test, t-score .3.0, corrected for multiple comparisons across space using permutation
testing, clustering determined using TFCE). Regions that showed significant decreases in GM density for longer pain duration included primary
sensory and motor regions, as well as insular cortex. D) Bargraph shows the mean +/- SD for GM density for the right insula for the short duration,
long duration and healthy groups. Insular mean GM density was significantly less for the long duration group when compared to short duration or
healthy groups. E) Scatter plots show the relationship between Insula GM density and duration for the short duration group (left panel, open circles)
and long duration (right panel, filled circles). The insula shows a significant relationship with pain duration only in the group when pain was
experienced for more than 5 years (R=0.71, p,0.01).
doi:10.1371/journal.pone.0026010.g002
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of its type and past about 5 years, imparts GM decrease in
proportion to the pain duration within a common set of brain
regions.
Chronic pain specifically disrupts whole-brain
morphological structure of the brain
Here we tackle the issue of the influence of local morphological
disturbances on the inter-relationship of morphology in relation to
other brain regions. Specifically we address the issue, given that
the different chronic pain groups exhibit distinct regional GM
density decreases, how do these local changes relate to the
morphological structure of the whole cortex? Whole-brain
anatomical organization can be abstracted by compiling a matrix
of correlations between all pairs of regions, averaged for
appropriate subject groupings. As the gross 82 ROI based VBM
data dramatically compresses representational dimensionality, it
can be readily used to generate such a matrix of associations
between (VBM derived and corrected) gray matter density
estimates for each pair of ROIs, in each group separately. Four
correlation matrices for the four groups are illustrated in
Figure 3A. Qualitatively we observe that, compared to the
Figure 3. Cortical structural covariance is specific for different chronic pain groups. A) Structural covariance was studied by calculating
pair-wise correlation of GM density between the 82 ROI-s across subjects separately for healthy controls, CBP, CRPS, and OA, after correcting for age,
gender, and total intracranial volume. Resultant correlation matrix shows widespread increases in correlation strength in all three patient groups. B)
Scatter plots show the left hemisphere pair-wise correlations (for the 41 ROIs) plotted against mean distance between pairs. Healthy subjects show a
linear dependency on distance. This relationship is disrupted in unique ways in each chronic pain condition. Green dots indicate the correlation of
one example region to the rest of the brain. C) Bar plots are the same data as in (B) after binning distances into 6 ranges, 25 mm each. Mean +/- SD
for pair-wise correlation coefficients are shown for each bin, in each group. Patients show higher correlations between ROIs that are far apart
(.100 mm apart; asterisks p,0.01 comparing means for each bin to its counterpart in the healthy controls). D) Spatial illustration of changes in
correlation for a frontal cortex ROI (same area illustrated in green in B). Significantly strong connections (r.0.6, p,0.05) are plotted (green lines) on
standard brain (black marks are centers of ROIs). Strong connectivity is observed with neighboring regions in the healthy group, while all three
chronic pain patient groups show enhanced long distance connections.
doi:10.1371/journal.pone.0026010.g003
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all three patient groups show increased correlation strengths
(positive and negative) for many pairs of ROI-s. To visualize the
spatial properties of these correlations, we displayed the strength of
the correlations as a function of the physical distance between any
given ROI pair, for each hemisphere. For the left hemisphere
(Figure 2B, left panel), healthy subjects showed a linear
relationship between correlation strength and distance (R=0.67,
p,0.01). Thus, whole-brain GM density structure can be captured
by this simple linear rule, which shows that ROIs that are located
close to each other are more similar in GM density than those
farther apart, and the decrement in GM density similarity is
proportional to the distance separating the involved regions. Yet,
this rule may have local exceptions, as there are large scatter of
values away from the linear fit. This relationship was attenuated
for CRPS (R=0.29, p,0.05) and disturbed for CBP (R=0.12,
p=0.18) and OA (R=0.09, p=0.31) (Figure 2B right three
panels). Comparison of the slopes of each pain group to that of
healthy controls yielded significant differences (p,0.01 for each
comparison). Qualitatively we observe that the shape of the cloud
of scatter of points is distinct for each chronic pain group. Within
the 2-dimensional correlation-to-distance space, CBP group shows
less observations in the right lower corner and increased points in
the right top corner; CRPS group shows more values throughout
the right half of the space; and OA group observations seem to
expand and fill all quadrants of the space. These distinct patterns
suggest that the whole-brain inter-relationship of GM density is
uniquely shifted in each chronic pain patient group. Some of these
between group structural differences can be captured quantita-
tively by binning the distances (Figure 3C, 6 bins of 25 mm each).
All three patient groups show significantly higher mean correlation
(mean of coefficients for all voxels within bin) compared to controls
for ROI-s that are physically separated by 100, 125 and 150 mm.
In addition OA patients exhibit the most variability in connectivity
strength for any distance (size of SD).
To illustrate the global disruption of correlations across the
brain, we examined a single (arbitrarily chosen) frontal ROI and
its strength of connectivity across the four groups. The distribution
of correlation values for this ROI closely mimic that seen across all
ROIs for each grouping (Figure 3B). By applying a significance
threshold (correlation values R.0.6, corrected for multiple
comparisons using Holm-Bonferonni) we can observe the spatial
distribution of the strongest correlations between GM density in
this region and the rest of the brain. Figure 3D illustrates these
connections on the left hemisphere, where again we observe
strengthening of long distance correlations in the three chronic
pain groups in contrast to the healthy subjects in which case strong
correlations are localized to the neighborhood of the ROI.
Subject classification based on gross brain morphology
Using three different approaches above we examined the
impact of chronic pain conditions on cortical morphology. Sum
total of these results suggest that the anatomy of the brain in
chronic pain is reorganized distinctly from that of healthy subjects,
and in a pattern unique for each of the pain conditions studied.
The latter implies that brain morphology may provide the means
by which individuals can be diagnostically classified to their
appropriate grouping. Here we devise a novel approach to identify
a ‘brain signature’ for the different conditions, and test its accuracy
in properly classifying individual brains. As the whole-brain
structural properties seem distinct for each chronic pain group, we
used GM density across all 82 ROI-s as the vector defining each
individual. Figure 4A shows the group average normalized GM
density for patients and healthy controls. Differences in the shape
of these vectors reflect average group brain regional distinctions of
GM density, which emphasizes within subject co-variation of GM
density. To further simplify this representation, these vectors were
binned into three categories (high GM density=+1, average GM
density=0, and low GM density=-1). The threshold was selected
to optimize differences between groups while retaining the
maximum amount of information (Figures 4B). This approach
emphasizes divergence from mean by marking peak changes and
thus reducing noise. The resultant ‘barcodes’ for the 4 groups are
displayed in Figure 4C. The pairwise correlations of the group
barcodes with each other are shown in Figure 4D. All groups
exhibited negative correlations with each other, with OA and
healthy being the most different (R=20.61) and OA and CBP the
most similar (R=20.23). Individual subject barcodes were
generated with the same approach. Calculating correlations
between each subject’s barcode to the 4 group barcodes assessed
the similarity of each subject’s brain morphology to the four
groups. The highest correlation coefficient was used to classify any
given subject to the corresponding category (Healthy, CBP, CRPS
or OA). Using this method we were able to classify with high
specificity (Healthy: 86.2%, CBP: 94.2%, CRPS: 92.2%, and OA:
90.9%) and sensitivity (Healthy: 80.0%, CBP: 81.2%, CRPS:
90.5% and OA: 72.6%). We also tested two other classification
techniques, logistic regression and artificial neural networks, and
these resulted in similar performance accuracies as the simple
maximum correlation method (data not shown).
We also tested classification using a more restricted barcode by
including only ROI-s that exhibited largest differences in GM
density across groups (14 ROI-s that passed threshold,
Figure 1D). Using this 14 ROI barcode we were able to predict
each class with specificity (Healthy: 94.8%, CBP: 92.0%, CRPS:
96.9% and OA: 94.9%) and sensitivity (Healthy: 95.7%, CBP:
91.2%, CRPS: 94.1% and OA: 75.0%) (Figure 4E). The 14 ROI
based classification improves mainly sensitivity relative to the
whole-brain based results.
As the available data set remains relatively small, the above
classifications were based on average barcodes calculated across all
members of each group and then testing membership for each
individual. Thus it suffers from the bias of double dipping. To
overcome this bias we also tested classification, for the whole-brain
and 14 ROI barcodes, when subsets of subjects (5 and 10) were
used to determine the group barcode. The subset of subjects was
selected per group at random to generate the group barcode and
the sensitivity and specificity were computed using the rest of
subjects. This process was iterated 10 times resulting in mean+/-
S.D. sensitivity and specificity values for each condition and subset
size. Group average specificity and sensitivity values are shown in
Figure 4D. When the number of subjects was restricted to 5 to
generate group barcodes, for the whole-brain barcode we were
able to predict classes with high specificity (Healthy: 81.668.0%,
CBP: 80.868.9%, CRPS: 82.665.8%, and OA: 81.563.3%) and
sensitivity (Healthy: 39.6610.9%, CBP: 56.269.9%, CRPS:
38.6613.8% and OA: 46.568.2%), and for the 14 ROI barcode
we obtained better specificity (Healthy: 90.666.3%, CBP:
88.162.5%, CRPS: 91.065.1%, and OA: 85.064.0%) and
sensitivity (Healthy: 64.35612.45%, CBP: 82.9468.67%, CRPS:
60.00610.53% and OA: 50.0067.55%). When 10 subjects were
used to generate the group barcodes, for the whole brain barcode
we were able to predict the class with higher specificity (Healthy:
91.762.6%, CBP: 95.462.3%, CRPS: 92.364.0% and OA:
90.662.3%) and sensitivity (Healthy: 77.266.1%, CBP:
82.466.0%, CRPS: 78.266.2% and OA: 69.068.8%), and for
the 14 ROI barcode we did not improve specificity (Healthy:
92.264.0%, CBP: 94.962.8%, CRPS: 91.765.2% and OA:
Anatomical Changes in Chronic Pain
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accuracy. A) The GM density for each ROI was normalized within subject and averaged for each group. The four groups show distinct variations of
GM across the brain. Dashed lines are thresholds implemented to tag ROIs to three different classes, high (+1), average (0), or low (21) GM values. B)
Threshold was selected to optimize the difference between groups. Black trace shows the relationship between the sum of R (the sum of the pair-
wise correlations coefficients between the barcodes for the 4 groups) and threshold implemented to generate the bar graphs. The green trace
represents the amount of information measured as joint entropy for the 4 groups as a function of threshold. The 4 groups showed the most
difference at a threshold of 0.56 (vertical dashed line). C) Group barcodes derived for the data in (A) using the selected threshold. D) Pair-wise
correlations across the four groups for the selected threshold. All between groups correlations are negative. E) Sensitivity and specificity of correctly
identifying individual subjects to their respective group based on the maximum correlation of each barcode with group barcodes. Left panel is when
the whole-brain barcode, shown in C, is used. Right panel is the result when 14 ROIs that best discriminate between the groups (shown in Figure 1C)
were used. The procedure shows very high specificity and sensitivity, as random classification would correspond to 25% sensitivity and specificity.F )
Dependence of sensitivity and specificity on number of brains used to calculate average barcodes. Whole-brain or 14 ROI-based barcodes derived
from a subset of subjects per group (5 and 10 respectively) and classification applied to the rest of the subjects. Shown are mean6S.D. of specificity
and sensitivity from 10 iterations for random choices of 5 and 10 subject group barcodes. Specificity exhibited robust results for both tests, while
sensitivity seemed to be more dependent on the number of subjects used and the specific group tested.
doi:10.1371/journal.pone.0026010.g004
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5.58%, CRPS: 75.00612.14% and OA: 66.00611.25%) (Figure
4F). Overall, by increasing the number of subjects (from 5 to 10)
used to generate the average barcode we improve accuracy of
classification for both whole-brain and 14 ROI based barcodes,
and performance becomes similar to that obtained when barcodes
are derived from the complete data set. Interestingly, whole-brain
barcode performs better than 14 ROI based barcode when the
group averages are derived from the larger number of subjects.
The obtained accuracy of the approach is remarkable even when
very small numbers of subjects are used to generate the group
barcodes, attesting to the robust and homogeneous differences in
brain morphology between the groups.
To visualize the extent of the similarities and overlap between
groups and individuals, we computed a distance (d) between each
subject’s barcode and the 4 group barcodes, based on the
correlation coefficients. Figure 5 shows the relative distribution
of all subjects and the median and interquartile contours for each
group, for the whole-brain (Figure 5A) and 14 ROI barcodes
(Figure 5B). The groups are far more distinct for the 14 ROI
barcodes. This segregation implies that if we use a more complex
classification algorithm based on subdividing this 2-dimensional
space then we should be able to classify individual brains at even a
higher accuracy than shown above. This Figure also quantifies the
relative distances of brain morphology between groups and
individuals, and shows that CBP brains are most dissimilar to
healthy subjects’ brains, followed by OA, while CRPS brains have
the shortest distance to healthy subjects’ brains. Additionally, CBP
brains are far distant from CRPS or OA, and CRPS and OA are
much closer to each other than CBP brains.
Relating whole-brain morphological reorganization to
chronicity of pain
Here we investigate the relationship of the observed whole-brain
morphological changes to clinical characteristics. The relative
distance, Dd, for each individual patient from the mean
coordinates of healthy subjects (see Figure 5A) was computed
and submitted for correlation analysis with pain duration, intensity
and depression for each patient group independently. We found
that Dd, which signifies the degree of deviation of whole-brain
morphological co-variation from norm, is significantly related to
pain duration in all patient groups. Figure 6A shows the
relationship of Dd and duration of chronic pain in log scale.
The CRPS group showed the highest correlation (R=0.84,
p,0.01) followed by CBP (R=0.81, p,0.01) and OA (R=0.64,
p,0.04). When we compare the slopes between groups, only the
CBP and CRPS showed a significant difference (CBP b=0.087,
CRPS b=0.043, t-score=4.12, p,0.01). These results indicate
that pain duration and whole-brain gray matter reorganization are
interrelated, for durations spanning from 3 months to 42 years, for
all patient groups. In order to elucidate the temporal evolution of
this relationship, we investigate the linear relationship between Dd
and pain chronicity. We found that it significantly followed an
exponential growth function in CBP (R=0.82, p,0.01) and
CRPS (R=0.81, p,0.01), but not in OA (exponential and linear
fits do not differ in OA, yet it seems to have characteristics in
between CBP and CRPS) (Figure 6B). In addition the time
constant for the CBP was significantly larger in CBP compared to
CRPS (CBP t=11.72 years, CRPS t=1.71 years, t=6.30,
p,0.01). These results directly link gross whole-brain reorganiza-
tion to the main clinical parameter, its chronicity, and indicate
that the deviation of the GM network from the normal brain is
about twice as large and 6 times slower in CBP than in CRPS. It is
worthy to note that Dd did not show any significant relationships
with pain intensity or depression.
Discussion
Our results show that different clinical chronic pain conditions
are associated with unique brain morphological changes, both
locally and grossly when GM is viewed as an interconnected
network. In addition, the impact of extent of chronicity of pain
imparts regional voxel-wise decreases in GM shared across the
groups investigated, and yet reorganizes the GM as a network to
distinct amounts and at distinct rates in some of the groups
studied. We utilized different approaches to quantify and compare
structural changes at different spatial scales: 1) we assessed whole-
brain cortical volume to examine global changes in brain
structure. This parameter was only reduced in CBP and is
consistent with our previous reports in which we observed
decreased whole-brain volume in CBP [9] but not in CRPS
[15]. 2) We used voxel-based morphometry (VBM) to assess
localized changes in GM density and observed only regional GM
decreases, which were more similar between CBP and OA, and
distinct in CRPS. 3) When VBM data was contrasted between
long and short duration chronic pain groupings, we observe
somatosensory, insular and motor regions exhibiting decreased
GM and specifically show that the insula GM decreases with a
characteristic time constant only when pain is maintained for .5
years. 4) We parceled the brain to 82 brain regions approximating
Brodmann Areas and generated a structural covariance to map
Figure 5. Individual brain and group GM interrelationships
based on barcodes. A) Whole-brain group-averaged barcodes
(Figure 4 C, D, E) were used to localize the relative relationship
between individual brains (left), and group averages (right). B) Same as
A except the barcode is derived from the 14 ROI barcodes (Figure 4 F).
The distance from the three poles and from the center (corresponding
to healthy controls) was computed from the correlation of individual
subject barcode with the 4 group barcodes. Left panels localize
individual brains relative to the center (healthy controls) and poles of
the equilateral triangle defining the three patient groups. Right panels
show the bi-median (cross) and 2-dimensional inter-quartile distances
(color contours) of each group relative to the center and poles of the
triangle. Different colors represent different groups. Outliers are shown
as stars (three CBP and one healthy control brains).
doi:10.1371/journal.pone.0026010.g005
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The latter analysis showed that the OA brain is the most disrupted,
and that all three pain patient groups’ brains show distinct patterns
of reorganization relative to healthy controls. 5) We used the 82-
region parcellation to generate a barcode and demonstrated that
this measure can robustly classify individuals to their respective
groupings, and this approach demonstrated that CBP brain as a
co-varying network is most distinct from healthy subjects while OA
and CRPS are more similar to each other and to healthy brains. 6)
Finally, the barcode analysis also led to quantifying the extent and
rate of change of the brain GM network with pain chronicity.
Whole-brain VBM, where GM density is contrasted between
subject groups for each GM voxel, remains the most commonly
used tool to assess brain morphological changes in humans. Since
the first report of brain grey matter distortions in chronic back
pain [9], a rapidly accumulating literature has been documenting
evidence for brain morphological changes in diverse clinical pain
conditions (see above), all of which are based on voxel-wise
comparisons of either GM density or GM thickness. Here, using
voxel-wise VBM contrasts, we observe that all three patient groups
showed decreases in regional GM density compared to respective
matched healthy controls. The CBP group showed the most
spatially extended pattern. The OA patients exhibited voxel-wise
decreased GM density in many of the same regions as in CBP, and
the OA results agree with earlier observation regarding GM
decreases in the hippocampus [17], and insula and S2 [16].
Decreased gray matter in CRPS was restricted to anterior insula
and parts of the orbital frontal cortex, closely replicating our
previous observations [15]. Although a few studies have reported
regional increases in GM in some pain conditions [24,37,38], the
most common observation has been decreased GM density or
thickness, and the present results confirm the latter for three
chronic pain conditions.
Do chronic pain patients have a common brain GM distortion
signature? Based on the results of a meta-analysis of VBM changes
in 12 different patient cohorts, May [39] argues that chronic pain
conditions are associated with structural changes within a common
set of brain regions involved in pain perception and modulation,
with the cingulate and insular cortices exhibiting most consistent
decreased GM density in the cohort. Evidence for this claim is
supported partially by the results in this study. For example all
groups exhibited decreased GM in the insular cortex. In addition,
the CBP and OA groups exhibited similar GM density decreases
especially in the cingulum, S1, and S2 cortices. Furthermore
duration of chronicity of pain, examined across all patient
populations, was associated with additional GM decreases in
brain regions known to receive nociceptive inputs and involved in
pain perception and modulation, namely insula, S1 and S2 [2,3].
However, despite these similarities, our data also showed non-
overlapping GM density decreases in diverse brain regions.
Indeed, brain areas that exhibited the most change in GM density
across the three patient groups included the hippocampus,
multiple lateral frontal regions and portions of the occipital lobe,
demonstrating that morphometric changes are not limited to pain
specific regions, but may reflect specific behavior and physiological
changes associated with prolonged coping with persisting pain.
If, instead of using voxel-based contrast, we parcel the brain into
82 ROI-s and normalize ROI GM values relative to within subject
variability, then fourteen gross brain regions distinguish between
the four groups. Many of these ROIs coincide with the regions
Figure 6. Relating whole-brain GM reorganization to pain chronicity. A) Scatter plots show the relationship between relative bar-code
distances, Dd, for individual patients and duration of chronic pain in CBP (red), CRPS (yellow) and OA (blue). The relative distance was computed as
the Euclidean distance between individual patients’ location in the ternary plot from the center for the mean of healthy controls (Figure 5A), thus
reflecting extent of global gray matter reorganization, where larger distances indicate larger deviations form healthy. All patient groups exhibited a
significant correlation between the distance and duration of pain in log scale. B) Same data in A plotted as a linear function of pain duration. Distance
relationship to pain duration followed an exponential growth function in CBP (left plot, red circles) and CRPS (middle plot, yellow circles), but not in
OA (right) plot. Yellow and red traces in right plot show the best fitted curves for CBP and CRPS respectively.
doi:10.1371/journal.pone.0026010.g006
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group specific barcode, which enables using within subject
variability of gross GM values as a biomarker of chronic pain.
We demonstrate that, using whole-brain or 14-ROI based
barcodes we can accurately classify subjects to their respective
groups, and localize individual brains in relation to the group and
in relation to other groups. This approach has the potential of
being used in comparing between different disease states and
treatments, especially in chronic pain where large co-morbidities
are commonly assumed [40], as well as within and across various
neurodegenerative conditions.
The reduced dimensionality of the ROI based analysis provides
the means for examining across regional co-variations, a method
adapted from recent techniques used to analyze network
properties of GM [34,41,42]. With this approach we reveal that
the brain GM as a network shows a simple linear distance
dependence in healthy controls. To our knowledge, this is the first
demonstration that gross BA-based brain network organization
tightly reflects the distance separating pairs of BA-s from each
other, and this dependence is most likely a reflection of genetic and
developmental competitive processes underlying maturation of the
cortical mantle. The current study is also the first to examine
anatomical GM networks in chronic pain. All patient groups
exhibited changes in inter-regional connectivities compared to
healthy controls, and uniquely distorted distance dependencies,
especially between non-adjacent regions (more than 100 mm
apart). The observed increases in GM density across non-adjacent
regions may reflect physiological changes in wide-brain distributed
functional networks. This is supported by recent evidence which
showed that in healthy subjects nodes within each functional
network exhibited tightly correlated gray matter volumes [41].
Similar whole-brain reorganization was recently demonstrated
using a very different approach: the linear relationship between
white-matter anisotropy to total gray matter volume seen in
healthy subjects is disrupted in CRPS patients [15]. Recent
evidence shows that functional specialization can lead to related
anatomical changes and regions that are anatomically connected
exhibit strong correlations in cortical thickness [42], perhaps
because connectivity confers a mutually trophic effect on
reorganization of connected regions, based on Hebbian plasticity
rules [43,44]. Moreover, whole-brain anatomical networks seem to
possess a degree of organization consistent with brain functional
networks [33,34]. Furthermore, such anatomical networks exhibit
specific reorganization in schizophrenia (Bassett et al., 2008) and
neurodegenerative diseases [41]. As we demonstrate that the gross
GM network reorganization has characteristic time constants,
distinct patterns of reorganization, and distinct magnitudes of
deviation from the normal brain, we conclude that each condition
uniquely impacts on the brain. As we observe that regional
decrease in GM density, for example in the insula, also exhibits a
characteristic time constant (slope of log-linear plot), we infer that
the whole-brain time constants should reflect anatomical and
functional reorganization for local changes as well as related
functional and anatomical connectivity changes, each of which
most likely possesses specific time constants. Thus, we can
conclude that living with distinct chronic pain conditions confers
a brain anatomical network reorganization, reflecting at least in
part a physiological reorganization, that must be the result of the
sum total of experiential changes (coping and suffering that result
in novel associations and deficits in learning, in memories and
valuation [45], and in extinction of memories [2,31]), as well as
peripheral and spinal cord reorganization observed in animal
models [1]. Therefore, we conclude that GM distortions measured
locally or as a network can be considered not only as a robust
biomarker for chronic pain but also a specific biomarker that
differentiates between kinds of chronic pain, and as such may be
useful in disentangling between co-morbidities. Given that the
anatomy of the brain is uniquely re-organized for distinct chronic
pain conditions, one has to assume that the observed shifts reflect
unique cognitive abnormalities, which may be unraveled based on
the properties of the GM distortions. We have intentionally not
pursued the inter-regional connectivity differences between the
conditions studied, yet such contrasts would provide leads as to
underlying cognitive/emotional/sensory distinctions, as well as
suggest mechanistic differences regarding cortical plasticity for
various chronic pain conditions.
Technical issues
A notable concern is the reproducibility of VBM results for the
same patient population, within and across studies. The CBP
patients in this study showed a more spatially diverse pattern of
GM decreases compared to our previous report [9] and those from
another study[10]. We presume this difference is a consequence of
multiple small incremental improvements: higher strength magnet,
larger sample size, better quality control for acquired MRIs, better
matching of templates, corrections for confounds and other small
changes in analysis. Multiple investigators have examined brain
morphometry in fibromyalgia patients [11,12,13,14,46,47]. Most
show a regional decrease in grey matter density [12,46,47], one
shows an increase [11], and yet another finds no change at all [13].
Such variability of outcomes in a single chronic pain condition is
unlikely to be a reflection of the patients studied. Instead it is more
probably because of the fact that morphometric studies are
complicated and subtle technical differences can bias outcomes,
such as integrity of acquired MRIs, inadequate registration and/or
segmentation, and choice of statistical test (parametric or non-
parametric). We assume that the method we advance here, based
on parceling the brain to 82 ROI-s, will be more readily usable
across labs and might result in more reproducible outcomes, as the
technique may not even need high resolution MRIs and has the
potential of using MR images acquired in different labs and with
different scan parameters, all of this, however, remains to be tested
in the future.
An additional limitation of the study is the fact that chronic pain
patients use various analgesic drugs over many years, which might
confound observed brain morphological changes, as suggested
earlier [9,10] [15]. We quantified drug consumption using a
validated questionnaire [48], which reduces drugs used for
different durations and doses to a single scalar. This allowed us
to examine the effect of medication on grey matter changes using a
covariate analysis. No significant relationships in GM density with
drug use were observed.
Conclusions
We demonstrate that brain GM properties are distinct in three
chronic pain patient conditions at multiple spatial scales, locally
and globally: whole-brain, the brain parceled to 82 GM regions,
the brain as a network of 82 GM regions, and voxel-wise GM.
The regional GM values show highly specific group differences,
enabling classification of individuals to their conditions with high
accuracy. Additionally the impact of the extent of chronicity of
pain can be observed commonly for all conditions and as
characteristic time constants for reorganizing the brain GM
network. Specific distorted GM networks for each chronic pain
group studied suggests that the reorganization is related to the
disease properties and as such reflects the maladaptive physiology
of chronic pain. The profusion of brain anatomical reorganization
with chronic pain suggests that such conditions can be used as a
Anatomical Changes in Chronic Pain
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Given the diverse spatial and temporal evidence presented here
and shown in animal models [26,27] for brain anatomical
reorganization with chronic pain, a multiplicity of mechanisms
should underlie these changes.
Methods
Subjects
The pool of subjects that participated in this study included 46
healthy subjects (26 females, 20 males; age: mean=38.77,
s.d.=12.50 years), 36 CBP patients (13 females, 23 males;
average age: mean=48.20, s.d.=11.38 years), 28 CRPS patients
(24 females, 4 males; average age: mean=40.57, s.d.=7.4 years)
and 20 OA patients (4 females, 16 males; average age:
mean=53.50, s.d.=7.4 years). All procedures for this study were
reviewed and approved by Northwestern University ethics and
IRB committee. All participants reviewed and signed written
consent forms approved by Northwestern University ethics and
IRB committee. All participants were right-handed. Healthy
subjects, CBP and OA patients were recruited by newspaper ads
in Chicago area, whereas CRPS patients were recruited from
local clinics in Chicago and a clinic in Toledo, OH. All patients
were diagnosed by a clinician and fulfilled the International
Association for the Study of Pain (IASP) criteria, and had to
satisfy a specific list of inclusion/exclusion criteria. Patients were
excluded if they reported other chronic painful conditions,
systemic disease, history of head injury or coma, or psychiatric
diseases. Depression is a common comorbidity of chronic pain.
Therefore, patients reporting more than mild to moderate
depression, as defined by Beck’s Depression Inventory (BDI,
global score .19) were also excluded. No cutoff threshold was
used for anxiety.
Pain parameters and medication
All patients completed the short-form of the McGill Pain
Questionnaire (SF-MPQ) which includes a visual analog scale
(VAS) (0=no pain, 100=maximum imaginable pain) and pain
duration. Depression scores for all subjects that participated in
the study were assessed using BDI. All questioners were given
1 hour prior to brain scanning. Drug consumption was quantified
using the Medication Quantification Scale (MQS) [48], which
reduces drugs used for different durations and doses to a single
scalar. The clinical and demographic data, as well as pain-related
parameters for the CBP, CRPS and OA patients are presented in
Table S2.
Scanning parameters
We used a 3T scanner (Siemens, Germany) to acquire high-
resolution T1-anatomical brain images. For all participants,
MPRAGE type T1-anatomical brain images were acquired using
the following parameters: voxel size 16161 mm; TR, 2500 ms;
TE, 3.36 ms; flip angle=9u; in-plane matrix resolution, 2566256;
slices, 160; field of view, 256 mm.
Total gray matter volume estimation
All subjects were included for this analysis. The T1-anatomical
brain images were used to calculate cortical gray matter volume,
with skull normalized to a standard brain (to compensate for
body-mass variations), excluding the cerebellum, deep gray
matter and brainstem. T1-anatomical brain images were also
used to calculate skull-normalized lateral ventricular volumes (3
rd
and 4
th ventricles), using an in-house-made mask for this purpose.
SIENAX, (http://www.fmrib.ox.ac.uk/fsl/), was used to yield
estimates of volumes of interest [49,50], after automated brain
extraction and tissue segmentation. Statistical analysis to compare
group differences in total GM volume across groups was
performed using an ANCOVA in which the effects of intracranial
volume, age and gender were regressed out as covariates of no
interest.
Voxel based morphometry (VBM)
Regional gray matter density was assessed with VBM using
the optimized method and nonparametric statistical contrasts
[35,51]. The FSL 4.0 software was used for brain extraction
[50] and segmentation [52], and FMRIB’s Linear Image
Registration Tool (FLIRT) to spatially register the native
images. The protocol included the following steps: first, a left-
right symmetric study-specific gray matter template was built
from 80 gray-matter-segmented native images (20 images were
randomly selected from each group to minimize size of
population bias) and their respective mirror images that were
all affine-registered to a standard gray matter template (ICBM-
152). The gray matter volume images were then linearly
normalized onto this template. Finally, images were smoothed
with isotropic Gaussian kernel (sigma=3.5, FWHM=8 mm).
Subcortical regions, including the bilateral thalamus and basal
ganglia were excluded from the VBM and subsequent analyses
using an in-house-made mask since VBM can overestimate
periventricular volume loss due to spatial registration errors
[41,53].
To identify gray matter differences associated with each type of
chronic pain, each group was entered as a condition into a
separate model, and linear contrasts were performed against age
and gender matched healthy controls selected from the healthy
subject data pool. Significant changes in gray matter density were
assessed using permutation-based inference [54] to allow rigorous
comparisons of significance within the framework of the general
linear model with p,0.01. Group differences were tested against
5000 random permutations, which inherently and exactly
accounts for multiple comparisons. Age, gender and total
intracranial volume were used as variables of no interest. Group
contrast clusters were identified using threshold-free cluster
enhancement (TFCE) method, which bypasses the arbitrary
threshold necessary in methods that use voxel-based thresholding
and is more sensitive and interpretable than cluster-based
thresholding methods [55].
Regional based gray matter morphometry
We calculated GM density for 82 cortical regions in each
participant. Regions were defined anatomically by previous
template images (Pick-Atlas, Advanced Neuroscience Imaging
Research Core, http://www.fmri.wfubmc.edu; MRIcro, http://
www.sph.s.c.edu/comd/rorden/mricro.html) that were registered
with the gray matter volume maps by an affine registration. The
82 regions compromised 41 regions in each hemisphere
approximating classical Brodmann areas in addition to the
hippocampus and amygdala. A list of the regions is presented in
Table S3. The mean GM density for each ROI was computed as
the sum of GM density of all voxels within the ROI from the VBM
maps. We used linear regression to model the effects of age gender,
and total intracranial volume on the full set of individual GM
density measurements for each region. The residuals of this
regression, which represent the GM density measurements
corrected for age, gender, and total GM density, were used to
compare group differences for GM density for each ROI using 1-
way ANOVA.
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We used Pearson correlation as the metric of association
between corrected GM density estimates for each possible pair of
the 82 regions in each group separately. For each pair of brain
regions i and j, we computed the correlation in corrected GM
density over subjects. This resulted in a 82682 correlation matrix
representing the specific associations in corrected GM density
between all possible pairs of regions for each group. We also
investigated the relationship between the GM density association
and distance for all pair of regions. The physical distance between
a pair of regions i and j was calculated as the Euclidean distance:
! ((xi-xj)
2 + (yi-yj)
2 + (zi-zj)
2), where x, y and z represent the
coordinates of the center of gravity of each ROI in standard
space.
Barcodes
Individual subject whole-brain barcodes were generated using
the corrected GM density across all 82 ROIs as a vector. First, the
GM density for each ROI was normalized for each subject (z
transformation to reflect the deviation of GM density for a given
ROI from the subject’s mean GM density). The resultant vector
was binned into three categories using high and low thresholds
(high GM density=+1, average GM density=0, and low GM
density=21). Threshold was calculated by maximizing mutual
information based on joint entropy (using Mutual Info 0.9 package
in Matlab). Group whole-brain barcodes for each condition
(Healthy, CBP, CRPS and OA) were generated in a similar
fashion using the mean GM density for each ROI per condition.
We also generated 14 ROI-based barcode using the regions that
showed significant differences in GM density across all groups.
Group barcodes were either generated from the mean GM density
of ROI-s using all subjects in each population, or from a subgroup
(n =5 and n=10) selected at random from the pool of subjects.
To classify individuals into groups, individual barcodes were
correlated to the group barcodes resulting in 4 group specific
Pearson correlation coefficients. Individual subjects’ brains were
then classified based on the highest correlation coefficient.
Distance plots
To visualize the extent of similarities and overlap between
groups, individual subjects’ barcode based distances were plotted
in a Cartesian space with coordinates (xi,y i), where xi=xcbp.dcbp+
xcrps.dcrps + xoa.doa+xnormals.dnormals)/(dcbp + dcrps + doa + dnormals) and
yi=y cbp.dcbp+ ycrps.dcrps + yoa.doa +ynormals.dnormals)/ (dcbp + dcrps + doa +
dnormals). Where xcbp ycbp,x crps ycrps,x oa yoa and xnormals ynormals were
predetermined values and represent the coordinates of the 3 poles
of an equilateral triangle and its center respectively. dcbp,d crps, doa
and dnormals represent the distance of any given individual barcode
from the respective group barcode and was derived from the
Pearson correlation coefficient of individual and group barcodes
(with spatial transformation d=(r+1)/2).
To determine the median and interquartile distances for each
group in the 2-dimensional space defined by the equilateral
triangle, we used the bagplot function (Matlab), which is a
bivariate generalization of the univariate boxplot where the half-
space location of a point is computed relative to a bivariate dataset
(an extension of the univariate concept of rank) [56].
To examine the relationship between the barcode and clinical
characteristics, we measured relative distance between individual
patient brains and the mean location for healthy subjects, Dd.
These values were correlated to pain chronicity in log scale, as well
as fitted to an exponential growth curve, Dd=Ddo+Dd1(1-exp(-t/
t)), where t=duration of chronic pain, t is characteristic time
constant, and Dd1 is the asymptotic maximum deviation from
healthy subjects. Their relationship was also examined for pain
intensity and depression outcomes.
Supporting Information
Figure S1 Decreased Gray matter density in patients.
Detailed maps for gray matter morphological changes assessed by
voxel based shown in Figure 1b. Red-yellow regions represent
areas that exhibited significant decrease in GM density for each
chronic pain condition compared to healthy. List of Foci are
presented in Table S1.
(TIF)
Table S1 Peak foci for decreased GM density in
patients. List of brain regions that exhibited significant decrease
in gray matter density in patients compared to healthy. R=right;
L=left; H=hemisphere; BA=Broddmann area; Sup=superior;
Inf=inferior; Mid=middle. Ant =anterior. Coordinated in mm.
(DOC)
Table S2 Demographic and pain clinical parameters in
patients. Listed are the pain, mood and demographic data for
patients participated in the study. VAS=visual analogue scale;
BDI =Beck’s depression inventory, BAI=Beck’s anxiety inven-
tory. MQS=medical quantification scale. The VAS was comput-
ed from the McGill short-form questionnaire (sf-MPQ).
(DOC)
Table S3 List of the ROIs for the automated parcella-
tion. Listed are the names of regions and standard space
coordinates of the center. Coordinated in mm.
(DOC)
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